Regenxbio’s gene therapy for Duchenne muscular dystrophy has smashed the primary endpoint of its pivotal trial, securing a win for a biotech that has struggled in recent months under the weight of a ...

Genetic diseases impact almost 70-80 million people worldwide. Oftentimes, there are limited treatments that doctors can provide, leaving patients with few interventions to manage symptoms. Recently, ...

We’ve tested numerous red light therapy devices over several weeks to find which might show benefits in real-life scenarios, such as long sitting hours, post-workout soreness, and persistent lower ...